Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

11258	Companies
250087	Keywords
178497	Articles
135950	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 11/02/2026 at 15:05, 3 hours 15 minutes ago

Jaguar Health's Napo Pharmaceuticals Engages in Pediatric Gastroenterology Conference

Crofelemer Clinical Trials Pediatric Gastroenterology Intestinal Failure Parenteral Nutrition
PRESS RELEASE

published on 11/02/2026 at 15:00, 3 hours 20 minutes ago

CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
BRIEF

published on 10/21/2026 at 15:05, 12 days 3 hours ago

Jaguar Health's Treatment Shows Promise for Pediatric IF Patients

Napo Pharmaceuticals Crofelemer Pediatric Patients Intestinal Failure Parenteral Support
PRESS RELEASE

published on 10/21/2026 at 15:00, 12 days 3 hours ago

Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Jaguar Health announces success of crofelemer powder for oral solution in treating infant patient with congenital sodium diarrhea. Plans for NDA in 2027 for MVID treatment

Jaguar Health NDA Intestinal Failure Crofelemer Powder Congenital Sodium Diarrhea
BRIEF

published on 10/14/2026 at 22:20, 18 days 20 hours ago

Jaguar Health Announces Update on Special Stock Dividend

Crofelemer Nasdaq Ex-dividend Date Jaguar Health, Inc. Special Stock Dividend
PRESS RELEASE

published on 10/14/2026 at 22:15, 18 days 20 hours ago

Jaguar Health Provides Update Regarding Special Stock Dividend
Jaguar Health, Inc. provides update on special stock dividend payout and ex-dividend date for Series R Convertible Preferred Stock. CEO Lisa Conte comments on company's strategic focus and development program for oral crofelemer

Crofelemer Jaguar Health Lisa Conte Special Stock Dividend Series R Convertible Preferred Stock
BRIEF

published on 10/14/2026 at 15:05, 19 days 3 hours ago

Jaguar Health Releases Positive Preliminary Results from SBS-IF Study

Crofelemer Jaguar Health Intestinal Failure SBS-IF Study Ostomy Output
PRESS RELEASE

published on 10/14/2026 at 15:00, 19 days 3 hours ago

Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Napo Pharmaceuticals presents positive preliminary results for crofelemer powder in Type 1 short bowel syndrome patients at ACG 2026, focusing on reducing ostomy output and improving quality of life

Napo Pharmaceuticals Gastrointestinal Disorders Crofelemer Powder ACG 2026 Type 1 Short Bowel Syndrome
BRIEF

published on 10/13/2026 at 15:05, 20 days 3 hours ago

Jaguar Health Announces Record Date for Special Stock Dividend

Preferred Stock Clinical Development Jaguar Health Special Stock Dividend Intestinal Diseases
PRESS RELEASE

published on 10/13/2026 at 15:00, 20 days 3 hours ago

Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Jaguar Health, Inc. announces Special Stock Dividend for Jaguar Common Stock holders on October 13, 2026, with Record and Payment dates set. Company's CEO Lisa Conte shares perspective on rewarding stockholders and ongoing global development program

Crofelemer Preferred Stock Jaguar Health Clinical Milestones Special Stock Dividend

Accesswire

Published on 11/02/2026 at 17:00, 1 hour 20 minutes ago

PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/02/2026 at 17:00, 1 hour 20 minutes ago

QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
Published on 11/02/2026 at 16:15, 2 hours 5 minutes ago

ACCESS Newswire Launches SPOT, Seven AI Agents That Check Every Press Release Before Submission
Published on 11/02/2026 at 15:00, 3 hours 20 minutes ago

CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Published on 11/02/2026 at 14:00, 4 hours 20 minutes ago

GameSquare to Report Q3 2026 Financial Results on November 16, 2026

View all ACCESSWIRE

EQS Group

Published on 11/02/2026 at 18:00, 20 minutes ago

Helvetia Asset Management Ltd adopts a unified market presence
Published on 11/02/2026 at 17:47, 33 minutes ago

Key Figures 31.10.2026
Published on 11/02/2026 at 17:40, 40 minutes ago

VALBIOTIS SA: Valbiotis delivers a first order to its Chinese joint venture and targets a commercial launch in China by the end of 2026
Published on 11/02/2026 at 17:30, 50 minutes ago

GEVELOT S.A.: Weekly declaration of share buybacks – 11/02/2026 (French only)
Published on 11/02/2026 at 16:00, 2 hours 20 minutes ago

Shares Admitted to Trading and Total Voting Rights

Les Echos

Published on 11/02/2026 at 18:00, 20 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 11/02/2026 at 17:59, 20 minutes ago

Saint-Gobain completes the divestment of its Dahl specialist distribution business in Sweden, Norway and Denmark
Published on 11/02/2026 at 17:45, 35 minutes ago

Weekly share buyback
Published on 11/02/2026 at 17:41, 38 minutes ago

Monthly disclosure of the total number of shares and voting rights - October 2026
Published on 11/02/2026 at 15:25, 2 hours 54 minutes ago

Guillemot Corporation S.A. | Information regarding the total number of voting rights and shares 31/10/2026

View all LES ECHOS COMFI WIRE